Low-toxicity, long-circulating human interferon-alpha PEGylated mutants
Interferon-alpha (IFNα) analog proteins modified by chemical attachment of at least one hydrophilic polymer moiety, such as polyethylene glycol chain, are described. In one embodiment, the IFNα analog protein has an amino acid sequence that differs from a native human IFNα interferon-alpha by one or more amino acid residues in the N-terminal region, comprised of between about residues 1-27, inclusive, by one or more substitutions selected based on the amino acid residue at the corresponding position of a mature interferon-tau (IFNτ) protein. Methods of treating viral diseases and other disorders with the polymer-modified IFNα analog protein are also described.
1. A composition, comprising:
a protein having a sequence of amino acids identified as SEQ ID NO:48, wherein said protein is covalently attached to at least one hydrophilic polymeric chain, and wherein said protein covalently attached to at least one hydrophilic polymeric chain has a reduced cellular toxicity compared to the protein of SEQ ID NO:48; and
a pharmaceutically acceptable carrier.
2. The composition of claim 1 , wherein said hydrophilic polymeric chain is polyethylene glycol.
3. The composition of claim 2 , wherein said polyethylene glycol is a branched polyethylene glycol.